Lataa...
Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) begins as simple hepatic steatosis, but further progress to chronic liver diseases results in severe liver damage and hepatic failure. However, therapeutic options are scarce due to the lack of reliable human in vitro liver models for understandi...
Tallennettuna:
| Julkaisussa: | J Biol Eng |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6686528/ https://ncbi.nlm.nih.gov/pubmed/31406506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13036-019-0198-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|